MARKET

NAUT

NAUT

Nautilus Biotechnology Inc
NASDAQ
2.510
-0.110
-4.20%
After Hours: 2.520 +0.01 +0.40% 19:02 05/15 EDT
OPEN
2.590
PREV CLOSE
2.620
HIGH
2.590
LOW
2.470
VOLUME
333.15K
TURNOVER
--
52 WEEK HIGH
4.310
52 WEEK LOW
0.6200
MARKET CAP
318.97M
P/E (TTM)
-5.5556
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NAUT last week (0504-0508)?
Weekly Report · 5d ago
Most and least shorted small-to-mid-cap stocks
Seeking Alpha · 05/05 14:05
Most and least shorted healthcare stocks with up to $2B market cap in May
Seeking Alpha · 05/04 13:50
Weekly Report: what happened at NAUT last week (0427-0501)?
Weekly Report · 05/04 09:36
Guggenheim Remains a Buy on Nautilus Biotechnolgy (NAUT)
TipRanks · 04/29 11:39
Analysts Offer Insights on Healthcare Companies: Nautilus Biotechnolgy (NAUT) and Universal Health (UHS)
TipRanks · 04/28 22:00
Nautilus expects cash runway through 2027 while targeting oncology early access in H2 2026
Seeking Alpha · 04/28 21:02
Nautilus Q1 net loss narrows 12% to $14.7 million; R&D expense falls 16% to $9.7 million
PUBT · 04/28 20:31
More
About NAUT
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprises the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Company’s Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs. Its platform consists of integrated reagents, fluidics, imaging, and ultra-dense nano-array flow cells.

Webull offers Nautilus Biotechnology Inc stock information, including NASDAQ: NAUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAUT stock methods without spending real money on the virtual paper trading platform.